Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer

BACKGROUND: We previously reported high expression of vasohibin-1 (VASH1), which is specifically expressed in activated vascular endothelial cells, was a prognostic indicator of disease progression in prostate cancer. The aim of this study was to assess whether VASH1 expression at the area of normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Hiroaki, Kosaka, Takeo, Mikami, Shuji, Miyazaki, Yasumasa, Matsumoto, Kazuhiro, Kikuchi, Eiji, Miyajima, Akira, Kameyama, Kaori, Sato, Yasufumi, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828223/
https://www.ncbi.nlm.nih.gov/pubmed/29535800
http://dx.doi.org/10.18632/oncotarget.23011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828223/
https://www.ncbi.nlm.nih.gov/pubmed/29535800
http://dx.doi.org/10.18632/oncotarget.23011

Ejemplares similares